DCLD
DCLD
Cirrhosis is defined
histologically as a diffuse
hepatic process characterized
by fibrosis and the conversion
of normal liver architecture into
structurally abnormal nodules
Viral Hepatitis B, C.
Alcoholic liver disease.
Non-alcoholic fatty liver
disease (NAFLD).
Autoimmune hepatitis.
Primary biliary cirrhosis.
Secondary biliary cirrhosis
(associated with chronic
extrahepatic bile duct
obstruction).
Primary sclerosing cholangitis.
Hemochromatosis
Wilson disease.
Alpha-1 antitrypsin deficiency.
Granulomatous disease (eg,
sarcoidosis).
Type IV glycogen storage
disease.
Drug-induced liver disease (eg,
methotrexate, alpha
methyldopa, amiodarone).
Venous outflow obstruction
(eg, Budd-Chiari syndrome,
veno-occlusive disease).
Cardiac cirrhosis: chronic
right-sided heart failure,
tricuspid regurgitation
Alkalosis.
Hypokalemia.
GIT bleeding.
Hypotension.
Hepatotoxic drugs.
Infection.
Diuretic therapy.
General anesthesia.
1) Liver:
Hyper-bilirubinemia (d.t
secretory function of the liver).
Hypo-albuminemia (d.t
synthetic function) tissue
edema, ascites, pleural effusion.
Elevated liver enzymes as a result
of hepatocellular damage.
2) GIT:
Portal hypert
Variceal Bleeding
Ascites:
SBP
3) Renal: Hepato-renal Syndrome
A) Hepato-pulmonary
Syndrome (HPS)
This is the presence of abnormal
intrapulmonary vascular
dilatation that can cause
profound hypoxemia
(B) Porto-pulmonary
hypertension (PPHTN)
PPHTN is defined as the
presence of a mean PAP
greater than 25 mmHg in the
presence of normal PCWP.
and can be very difficult to
treat.
Anemia:
Thrombocytopenia
Coagulopathy
7) Metabolic changes:
8) CVS changes:
Hyperdynamic circulatory state due
to:
Peripheral vasodilation by
endogenous vasodilators that
bypass hepatic metabolism (NO
and glucagon).
Portal and systemic shunts.
Endoscopy
Gastric
lavage
anti-shock measures
Vasopressin infusion
Balloon tamponade
Emergency sclerotherapy
IV nitro-glycerine and
propranolol
Octreotide
H2 Blockers:
Lactulose
colonic lavage
Neomycin
Rifaximin
Flumazenil
Caloric requirements:
25-30 Kcal/Kg/day of
normovolemic BW.
Protein requirements:
NSAIDs
Isoniazide
valproic acid
Erythromycin
amoxicillin-clavulanate
Ketoconazole
chlorpromazine
Aminoglycosides are
considered obligate
nephrotoxins in patients with
cirrhosis and should be
avoided.
Acetaminophen
NSAID
Opiate